Fact CheckerSign in

NCT06227611Recruiting

Evaluation of Different Perimetric Grids to Detect Central Visual Field Defect in Glaucoma Patients With Reduce Ganglion Cell Layer Thickness Measured by Spectral Domain OCT.

Source: ClinicalTrials.gov · Last updated 3 Sept 2026

Brief summary (registry, in English)

The aim of the study is to evaluate the agreement between three different grids in detecting central visual field defect in early glaucoma patients with reduced ganglion cell layer thickness.

Status (registry)
Recruiting
Study type
Observational
Enrollment
16 (estimated)
First submitted
18 Jan 2024
Start date
4 May 2021
Primary completion date
4 May 2022
Lead sponsor
Fondazione G.B. Bietti, IRCCS
Diseases
Glaucoma
NCT number
NCT06227611

What you commit to

  • Study type: Observational
  • Planned participants: 16
  • From 4 May 2021 to the primary completion date, 4 May 2022
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • retinal or macular diseases

Age

  • age\<18 years

Other

  • unable to read, understand and sign the written informed consent
  • unable to perform visual field test
  • advanced glaucoma with C/D\>0.7
  • other causes of optic neuropathies
  • lens or corneal opacities
  • spherical refractive defect \>± 6D
  • cylindric refractive defect \>± 3D

Who the study is looking for

  • glaucoma patients with glaucomatous optic nerve head defect and reduced ganglion cell layer thickness

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Rome Tor Vergata
Coordinator of this site? Confirm its status
RomeItalyRecruiting
IRCCS-Fondazione GB Bietti
Coordinator of this site? Confirm its status
RomeItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.